Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Transcription regulator nuclear protein-1 (Nupr1) is a cell stress protein. Different external pressures and cell microenvironment can affect its expression and mediate its nuclear entry to regulate the transcription of various genes. This directly or indirectly triggers different intracellular signaling pathways and produces corresponding cytological effects, participating in the occurrence and development of tumors and non-tumor diseases.
Figure 1. A schematic illustrating the role of Nupr1 in METH-induced apoptosis and autophagy in neuronal cells. (Xu, X., et al. 2017)
In neoplastic diseases, Nupr1 can produce different effects in different tumor microenvironments, which can both promote and inhibit the progress of tumors, such as the same double-edged sword. In pancreatic cancer, tumor cells have high expression of Nupr1 (while high expression is not found in pancreatic fibrocysts and normal pancreatic cells), Nupr1 changes the level of DNA methylation by inhibiting the expression of DNA methyltransferase 1, inhibits Kirsten rat sarcoma virus proto-oncogene-induced cell death, and promotes pancreatic intraepithelial neoplasia. In breast cancer, the high expression of Nupr1 is an important factor for the poor prognosis of early breast cancer patients, and Nupr1 can promote the growth of human breast cancer cells in the inoculated organs, which has a certain relationship with its metastasis.
Nupr1 is moderately expressed in normal human lung tissue. Down-regulating its expression can not only reduce the proliferation of non-small cell lung cancer, in vitro clone formation and tumorigenicity in nude mice, but also block the cell cycle at G0/G1 period. In addition, it can promote cell death by regulating the autophagy tide. In medullary thyroid tumors, the expression level of Nupr1 is directly related to lymph node metastasis, and 24.8% of patients with higher Nupr1 expression relapsed. In prostate cancer cells, overexpression of Nupr1 can increase the sensitivity of cells to cycloglitazone and may act as a tumor suppressor.
In the acute phase of pancreatitis, Nupr1 expression is up-regulated, and P8 expression is also increased during pancreatic gland development and regeneration after resection. The researchers studied the response of the immune system of the spleen cells of the Knpr1 gene knockout rats and wild-type rats in acute pancreatitis, and found that Nu-pr1 may maintain the balance of the immune response by limiting apoptosis. At the same time, they also found that Nupr1 is involved in the cell's antioxidant defense mechanism.
In the psychic system, Nupr1 is a key gene for oxidative stress in astrocytes, and up-regulation of Nupr1mRNA expression can enhance the tolerance of cells to stress injury. Similarly, in human osteoarthritis cartilage, Nupr1 expression is higher than normal cartilage, and IL-1β stimulation can induce chondrocyte Nupr1mRNA expression to increase, which may be a new IL-1β regulated matrix metalloproteinase molecule pathway. Quantitative PCR method was used to detect the level of Nupr1 in mouse ovary, testis, liver and pancreas tissues, and it was found that Nupr1 expression could be detected in these tissues, and the level of Nupr1mRNA in ovarian and testicular tissues was much higher than that of pancreas and liver. Therefore, it is speculated that it plays an important role in ovarian maturation and the maintenance of normal testicular sperm count.
Nupr1 and the mechanism of diabetes and its complications are also the focus of research. Researchers found that in type Ⅱ diabetes, Nupr1 can affect the expression of heat shock protein 70, change the body's sensitivity to insulin, and thus affect blood sugar levels. Reducing the expression of Nupr1 can obviously increase the body's sensitivity to insulin, this research result provides a new idea for the treatment of type II diabetes. In an animal model of diabetic nephropathy treated with streptozotocin, induced by endothelin, angiotensin and glucagon, Nupr1 expression is up-regulated, which in turn stimulates mesangial cell hypertrophy.
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.